Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed

Wüsthoff, Linda Elise Couëssurel; Waal, Helge; Ruud, Torleif; Røislien, Jo; Gråwe, Rolf W.

doi:10.3109/08039488.2010.489954

Cited by 10 publications

(14 citation statements)

References 178 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent study of CMHCs in Norway, we found that only 10% of the patients had received ICD-10 diagnoses [14] of SUD [15]. The obvious explanation was under-detection by the clinicians.…”

Section: Introductionmentioning

confidence: 99%

A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres

et al. 2011

Self Cite

View full text Add to dashboard Cite

BackgroundEpidemiological studies have consistently established high comorbidity between psychiatric disorders and substance use disorders (SUD). This comorbidity is even more prominent when psychiatric populations are studied. Previous studies have focused on inpatient populations dominated by psychotic disorders, whereas this paper presents findings on patients in Community Mental Health Centres (CMHCs) where affective and anxiety disorders are most prominent. The purpose of this study is to compare patients in CMHCs with and without SUD in regard to differences in socio-demographic characteristics, level of morbidity, prevalence of different diagnostic categories, health services provided and the level of improvement in psychiatric symptoms.MethodsAs part of the evaluation of the National Plan for Mental Health, all patients seen in eight CMHCs during a 4-week period in 2007 were studied (n = 2154). The CMHCs were located in rural and urban areas of Norway. The patients were diagnosed according to the ICD-10 diagnoses and assessed with the Health of the Nation Outcome Scales, the Alcohol Use Scale and the Drug Use Scale.ResultsPatients with SUD in CMHCs are more frequently male, single and living alone, have more severe morbidity, less anxiety and mood disorders, less outpatient treatment and less improvement in regard to recovery from psychological symptoms compared to patients with no SUD.ConclusionCMHCs need to implement systematic screening and diagnostic procedures in order to detect the special needs of these patients and improve their treatment.

show abstract

“…In a recent study of CMHCs in Norway, we found that only 10% of the patients had received ICD-10 diagnoses [14] of SUD [15]. The obvious explanation was under-detection by the clinicians.…”

Section: Introductionmentioning

confidence: 99%

A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres

et al. 2011

Self Cite

View full text Add to dashboard Cite

show abstract

“…2006). The scale has good convergent (Wüsthoff et al 2011) as well as face validity, directly asking “Please rate your use of cannabis in the past 1 month according to the following scale: 0=”no use” to 5=”almost daily.” A urine sample was screened for the presence of tetrahydrocannabinol (THC cutoff 50 ng/mL) utilizing Instant Technologies iCup (Norfolk, VA). The rapid drug screen has detection times up to one month and is commonly used in drug research (McRae-Clark et al 2013).…”

Section: To the Editormentioning

confidence: 99%

Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado

Carol

Mittal

2014

Schizophrenia Research

View full text Add to dashboard Cite

“…This scale is among the most widely used in UHR programs (Buchy et al, 2015; Woods et al, 2009) and found to be highly reliable in psychosis populations (ICCs≥.93; Brunette et al, 2006). The scale has good convergent (Wusthoff et al, 2011) as well as face validity, directly asking “Please rate your use of cannabis in the past 1 month according to the following scale: 0 = “no use” to 5 = “almost daily.”…”

Section: Methodsmentioning

confidence: 99%

The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis

Carol

Spencer

Mittal

2017

Psychoneuroendocrinology

View full text Add to dashboard Cite

Recent studies have posited a relationship between cannabis use and the biological stress system, but this critical relationship has not been evaluated during the ultra high-risk (UHR) period immediately preceding the onset of psychotic disorders. Salivary cortisol samples were collected on 46 UHR and 29 control adolescents; these individuals were assessed for current cannabis use with a urine panel and self-report. UHR participants where separated into two groups: Current Cannabis Use (UHR-CU) and No Current Cannabis Use (UHR-NC). Healthy Control participants (HC) were free of cannabis use. Consistent with the literature, results indicate UHR individuals showed elevated cortisol levels when compared to HC participants. Further, we also observed that UHR-CU participants exhibited elevated levels when compared to both the non-using UHR and HC groups. Findings suggest that cannabis use may interact with underlying biological vulnerability associated with the hypothalamic-pituitary-adrenal (HPA) axis system.

show abstract

Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed

Cited by 10 publications

References 178 publications

A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres

A cross-sectional study of patients with and without substance use disorders in Community Mental Health Centres

Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado

The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis

Contact Info

Product

Resources

About